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a  b  s  t  r  a  c  t
In Denmark,  a monitoring  program  for residues  of  antimicrobials  in  pork  is in  place  involving  annual
testing  of around  20,000  samples  from  ﬁnishing  pigs  corresponding  to 0.1%  of the animals  slaughtered.
Annually,  zero  to two  samples  are  found  above  the  maximum  residue  limit.  Both  authorities  and  indus-
try have  expressed  interest  in  adjusting  the  monitoring  to a  risk-based  system.  The  objective  of  this
study  was to assess  the  opportunities  and  consequences  of the  monitoring  considering:  1)  replacing  the
current  bioassay  with  high-performance  liquid  chromatography–mass  spectrometry  (HPLC  LC–MS/MS),
2)  replacing  kidney  with  muscles  as sample  matrix,  and 3)  using  indicators  to identify  high-risk  (HR)
herds  and  increase  sampling  intensity  in  these  herds,  lowering  sampling  in the  low-risk  (LR) herds,  while
aiming  at  continued  detection  of  similar  numbers  of test-positives  at the  lowest  possible  costs.
A state-of-the-art  stochastic  scenario  tree modelling  approach  including  economic  evaluation  of  differ-
ent  model  outcomes  was  used.  A total  of  six  scenarios  were  run  for penicillin  and  tetracycline,  respectively.
Relevant  information  was  obtained  through  the literature,  statistical  analysis  of existing  data  as  well as
consultations  with  laboratory  and  slaughterhouse  experts.  Abattoir  recordings  of chronic  pleuritis  were
used as  an  indicator  for  ﬁnishing  pig  herds  (HR  = within-herd  prevalence  >  40%).  Such  risk-based  monitor-
ing  would  have to use  muscles  and  not  kidneys,  because  of logistic  challenges  in  identifying  and  storing
of  plucks  until  testing.  However,  the  bioassay  cannot  be used  on  muscle  tissue  due  to  low  sensitivity  for
tetracyclines.  Different  plausible  combinations  of  sample  sizes  were  also  modelled.
The  HPLC  LC–MS/MS  method  detected  the  same  number  of  cases  compared  to the  bioassay  when  kidney
was used  as  matrix.  HPLC  LC–MS/MS  has  a higher  sensitivity  when  used  on  muscle  but  it is  almost  twice
as  costly  as the  bioassay.  Risk-based  sampling  resulted  in detection  of  more  residue  cases  with  higher
cost-effectiveness  than random  monitoring.  Sampling  7500  HR  pigs  and  5000  LR  pigs  resulted  in the
most  cost-effective  monitoring  among  the  alternative  scenarios.  The  associated  costs  would  increase  by
4%.  A  scenario  involving  testing  of  5000  HR  and  5000  LR animals  would  result  in slightly  fewer  positives,
but  17%  savings  in costs.  The  advantages  of  using  HPLC  LC–MS/MS  compared  to  the  bioassay  are  a  fast
response  and  a high  sensitivity  for all  relevant  substances  used  in  pigs.  The  Danish  abattoir  companies
have  implemented  a  risk-based  monitoring  similar  to the  above  per  January  2016.
©  2016  Elsevier  B.V.  All  rights  reserved.. Introduction
Withdrawal periods for veterinary medical products are estab-
ished to prevent treated animals and hereby products from treated
nimals from entering the food chain too soon after treatment.
uch withdrawal periods are based on Maximum Residue Limits
MRL). However, if the withdrawal periods are not complied with,
∗ Corresponding author.
E-mail address: lia@lf.dk (L. Alban).
ttp://dx.doi.org/10.1016/j.prevetmed.2016.04.007
167-5877/© 2016 Elsevier B.V. All rights reserved.residues of pharmacologically active substances or their metabo-
lites above MRL  might be found in animal-derived food products,
posing a potential risk to human health (Anon., 2010).
The European Union (EU) Member States are required to imple-
ment residue monitoring in live animals and animal products
(Anon., 1996). The EU Directive 96/23 prescribes that a minimum
of 0.01% of the pigs slaughtered annually in each country are tested
for residues of antibacterial substances through ofﬁcial monitor-
ing (Anon., 2009). Currently, the annual number of ﬁnishing pigs
slaughtered in Denmark is around 20 million. Around 2000 samples
– corresponding to 0.01% of the slaughter population – are tested for
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esidues of antimicrobials through the ofﬁcial Danish national mon-
toring program. Another 17,000 samples (0.085%) are collected and
ested for residues of antimicrobials through the Danish abattoirs’
wn-check program, which is described below. Hence, the entire
onitoring for antimicrobial residues includes close to 0.1% of the
nishing pigs slaughtered in Denmark.
The substances found in the residue surveillance are not reﬂect-
ng the general use of antimicrobials in pigs, because injectables
n general have a higher likelihood of resulting in presence of
esidues in the meat than per oral medicine, which is not neces-
arily absorbed but acting locally in the intestines (Alban et al.,
014). Furthermore, residues are more likely to be present in ani-
als treated close to time of slaughter, and therefore are more likely
o be found in slaughter pigs that have recently been ill.
In the Danish own-check, samples are analysed by use of a
ioassay consisting of a microbiological four-plate test (NMKL
21, 2004) followed by a chemical veriﬁcation. Since 2013, the
hemical veriﬁcation consists of using high-performance liquid
hromatography–mass spectrometry (HPLC LC–MS/MS). More-
ver, since January 2013 samples are analysed directly by HPLC
C–MS/MS in the national program (Olsen, 2015). Currently, the
anish abattoir companies are considering replacing the bioassay
ith HPLC LC–MS/MS. This would eliminate the potential problem
elated to using different analytical methods in the two parts of the
rogramme.
Monitoring data collected over more than a decade indicate that
he true prevalence of antimicrobial residues above the MRL  is neg-
igible in Danish ﬁnishing pigs (around 0.01%) (Baptista et al., 2012).
n this situation, a risk-based approach targeting the monitoring
ctivities to high-risk sub-populations might make it possible to
educe the number of samples taken without jeopardizing food
afety, or even potentially improving food safety (Stärk et al., 2006;
adorn and Stärk, 2008; Presi et al., 2008; Baptista et al., 2012).
According to the EU Directive, national residue monitoringhould – in general – be targeted to high-risk animals using the
ollowing minimum criteria: sex, age, species, fattening system,
ll available background information, and all evidence of mis-
se or abuse of antimicrobials (Anon., 1996). In Denmark, this isg system for detection of antimicrobial residues given true antimicrobial residue
risk and low-risk groups, respectively. . PropHR is the proportion of ﬁnishing pigs
interpreted as a higher sampling intensity in sows compared to
ﬁnishing pigs as well as repeated testing in herds with previous
ﬁndings of antimicrobial residues. In a future revision of the EU
Directive, which is expected within in a few years, the goal is most
likely to adopt a more risk-based monitoring.
The objective of this study was  to investigate the opportunities
and consequences of a risk-based approach to monitor antimicro-
bial residues in the Danish ﬁnishing pigs at slaughter. The speciﬁc
objective was to compare the performance of two  different diag-
nostic tests (HPLC LC–MS/MS versus a biological method) and
sampling strategies (risk-based versus random). To enable such
comparisons, a stochastic scenario tree model was built for estima-
tion of costs and effects of changed sampling and testing strategies.
2. Materials and methods
The selected approach to address the study objectives is adapted
from a state-of-the-art method developed over the last decade for
use in quantitative veterinary epidemiology related to evaluation
of the performance of surveillance programs. The approach is well-
described and exempliﬁed in international publications (Martin
et al., 2007), and has been used in previous studies of related nature,
e.g. Hadorn and Stärk (2008), Alban et al. (2008), Calvo-Artavia et al.
(2012) and Foddai et al. (2015).
2.1. Scenario tree model structure
A stochastic scenario tree is a way to describe the detailed struc-
ture of the different components of a surveillance programme. The
tree consists of mainly three different types of nodes: infection
nodes, detection nodes and category nodes (Fig. 1). A stochastic sce-
nario tree simulation model was  developed as described by Martin
et al. (2007), but modiﬁed to ﬁt the circumstances being modeled
here. The terminology and abbreviations are also slightly different
from those used in the original publication by Martin et al. (2007)
to describe the system being modeled.
The population of ﬁnishing pigs slaughtered in Denmark dur-
ing a 1-year period (Spop) was divided into subpopulations. Within
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Table  1
Description of scenarios simulated to study effect of changing analytical method, matrix, way of sampling, respectively, in the monitoring of residues of antimicrobials in
Danish  ﬁnishing pigs.
Scenario number
1a 2 3 4 5 6
Analytic method Bioassayb +
HPLC LC–MS/MS + + + + +
Matrix Kidney + +
Muscle + + + +
Way  of sampling Random + +
Risk-basedc (RR = 2) + +
Risk-basedc (RR = 3) + +
Sample size 20,000 + +
5,000HRd + 5000 LRd + +
7,500HRd + 5000 LRd + +
a Current scenario.
b The bioassay consisted of a biological four-plate method (NMKL 121, 2004) followed by chemical veriﬁcation of positive samples.
c It was  assumed that ﬁnishing pigs from herds with >40% prevalence of chronic pleuritis were associated with RR = 2 or RR = 3 of detecting residues at slaughter compared
to  pigs from herds with a prevalence ≤ 40% − based on Alban et al. (2014).
d HR = high risk; LR = low risk.
Table 2
Results of monitoring for antimicrobial residues in Danish ﬁnishing pigs, for the ofﬁcial and own-check program, respectively, for the years 2005–2013, covering the two
largest  slaughterhouse companies in Denmark, representing around 88% of the ﬁnishing pigs produced annually.
Kind of monitoringYear Total No. of samples No. of conﬁrmed samples >MRLa Substances identiﬁed
Ofﬁcial programb
2005 1002 0 n.r.
2006  1009 0 n.r.
2007  804 0 n.r
2008  809 0 n.r
2009  812 0 n.r.
2010  1414 0 n.r.
2011  1427 0 n.r.
2012  1426 0 n.r.
2013  1628 0 n.r.
Own-check programc
2005 18,910 0 n.r.
2006  17,956 1 Benzylpenicillin
2007  17,612 1 Benzylpenicillin
2008  22,806 2 Doxycycline & Benzylpenicillin
2009  21,686 1 Doxycycline
2010  16,191 2 Benzylpenicillin (2)
2011  19,361 0 n.r.
2012  14,240 1 Tularthromcind
2013 14,262 0 n.r.
n.r. = not relevant.
a MRL = Maximum residue level accepted legally.
b From 2007 to 2012, the ofﬁcial samples were analysed by use of a bioassay consisting of a biological four-plate method (NMKL 121, 2004) followed by chemical veriﬁcation,
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thile samples from 2013 were analysed using HPLC LC–MS/MS directly (Olsen, 201
c Samples taken as part of the own-check program were analysed by use of the b
d Tularthromycin belongs to the macrolide group.
ach of the subpopulations, all animals were assumed to have equal
robability of being test-positive in the basic scenarios. The unit of
oncern was the individual pig rather than the whole herd. Proba-
ilities for the possible outcomes were estimated for each branch
f the scenario tree (Fig. 1). Six trees were constructed represent-
ng random and risk-based sampling, use of two different analytical
ests, two different assumptions regarding high-risk and low-risk
opulation strata, and two different sampling strategies (Table 1).
he investigation was limited to antibiotic residues grouped as
enicillin or tetracycline, respectively. These two drug classes rep-
esent the vast majority of ﬁndings of antimicrobial residues in
anish ﬁnishinig pigs (Table 2).
.2. Population and risk factorsIn the simulations, the annual number of ﬁnishing pigs slaugh-
ered was by default set to 20 million ﬁnishing pigs. This is close to
he production achieved in the years 2007–2013.y.
Two  risk factors/indicators related to presence of antibiotic
residues have previously been identiﬁed: i) prior ﬁndings of
residues in a herd (Alban et al., 2011) and ii) a high within-herd
prevalence of chronic pleuritis (Alban et al., 2014). The ﬁrst was
considered to have limited practical impact in Denmark, because
of the low number of positive ﬁndings (≤2 in total per year in
ﬁnishing pigs—Table 2). The latter was  based on a study of nine dif-
ferent meat inspection lesions in ﬁnishing pig herds between July
2010 and December 2012. The prevalence of the different lesion
codes was  compared between ﬁnishing pig herds with ﬁndings of
residues and similar herds delivering to the same abattoir in the
same time period (Alban et al., 2014). Based on this analysis, it was
concluded that only chronic pleuritis could be considered an indi-
cator for increased risk of residues of antimicrobials. The risk of
ﬁnding residues was around twice as high (RR = 2) in pigs com-
ing from herds with a within-herd prevalence >40% compared to
herds with a prevalence ≤40%). This is supported by a pilot study
from the Netherlands, which indicated a 3.2 times higher prob-
ability (95% C.I. of RR: 1.2–8.5, P = 0.01) of ﬁnding antimicrobial
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esidues in herds with a within-herd prevalence of pleuritis/lung
esions more than twice as high as the average (Jelsma et al., 2006).
t was therefore decided to run one scenario assuming RR = 2 and
nother scenario assuming RR = 3 (Table 1).
This herd-level cluster-effect was taken into account in the
odel by the ﬁrst node in the scenario tree for scenarios 3–6. This
ode was a category node that divided all slaughtered animals into
roportions of high-risk (PropHR) and low-risk (PropLR) for each risk
actor group.
The average within-herd prevalence of chronic pleuritis in Dan-
sh ﬁnishing pigs is around 20%. Based on data from Danish pig
roduction, Alban et al. (2014) calculated that a cut-off of a within-
erd prevalence of 40% would include around 25% of the herds in
he HR-group.
.3. Probability of presence of antimicrobial residues
The next node in the scenario tree was an infection (residue)
ode, in which the estimated true animal-level residue prevalence
PA) was used in the calculations to obtain effective probabili-
ies of residue presence (EPP) within each subpopulation deﬁned
y the previous category node. To describe the true antibacterial
esidue prevalence PA in a ﬁctive year, we used the distribution
ert(0.00146%;0.0096%;0.034%). This was based upon Baptista et al.
2012) who provided estimates of PA based on data from the Dan-
sh ﬁnishing pig surveillance for the time period 2005–2009. The
ode was calculated as the mean of each year’s median, whereas
he min  and max  were obtained as a mean of the lower and higher
nd of each year’s 95% credibility interval.
One of the most common ﬁndings of residues is benzylpenicillin,
hich is an injectable belonging to the penicillin G group (Table 2).
he proportion of samples, where penicillin G was  found in ﬁn-
shing pigs in the years 2005–2013 was 5/8. This proportion was
ultiplied by the true prevalence of residues PA to obtain the preva-
ence of residues due to penicillin G PAP . Although tularthromycin –
 macrolide – represents another class of antibiotics, the sensitivity
Se) and the speciﬁcity (Sp) in the HPLC LC–MS/MS are the same as
or penicillin (100%) according to the laboratory experts. Therefore,
he ﬁnding of tularthromycin residues was added to the penicillin
roup to avoid not accounting for one ﬁnding of residues out of the
ight, observed during the study period 2005–2013. Likewise, the
roportion of samples where tetracycline residues was found in
nishing pigs was 2/8. This proportion was multiplied by the true
revalence of residues PA to obtain the prevalence of residues due
o tetracycline PAT .
The relative risks (RR) for the high-risk (HR) group compared
o the low-risk (LR) group, and the proportion of animals in the
R group were used for calculation of the adjusted risk (AR) for
he LR group (ARLR) and multiplied by the RR to obtain the AR of
he high-risk group (ARHR) (Martin et al., 2007). Finally, the ARs
ere multiplied by PA to calculate the EPP for each risk group (EPPLR
nd EPPHR) as shown in Eqs. (1) and (2), and the probability of no
esidues present in the sample was calculated as (1-EPP)  (Calvo-
rtavia et al., 2012).
PPLR = (1/(RR × PropHR + (1 − PropHR))) × PA (1)
PPHR = ((1/(RR × PropHR + (1 − PropHR))) × RR)  × PA (2)
here:
EPPLR is the effective probability of residue presence in the ani-
als in the low-risk group,
EPPHR is the effective probability of residue presence for the
nimals in the high-risk group,
RR is the relative risk in the high-risk compared to the low-risk
roup,y Medicine 128 (2016) 87–94
PropHR is the proportion of all slaughtered pigs in the high-risk
group and
PA is the assumed true animal prevalence.
2.4. Scenarios to evaluate
The next node in the scenario tree was  a detection node deter-
mining the frequency of sampling and testing of the pigs in the
different branches. According to the group categorisation of the
population in HR and LR groups, six scenario trees were consid-
ered: one scenario representing the current surveillance system as
well as ﬁve risk-based alternatives. The alternative scenarios were
constructed in a way  that allowed all animals in the HR-group to be
subjected to an increased probability of testing, while all animals
in the LR-group were subjected to a lower probability of testing
(Table 1).
There were three variables to be studied in combination: 1)
diagnostic method (HPLC LC–MS/MS versus bioassay, 2) choice of
matrix (muscle versus kidney), and 3) way  of sampling (risk-based
versus random). However, a dialogue with the slaughterhouse
experts revealed that risk-based monitoring based on chronic
pleuritis would have to involve muscle samples and not kidneys,
because of logistic challenges in identifying and storing of plucks
until testing. Moreover, according to the laboratory experts, for
muscle as a matrix the bioassay cannot be used as laboratory
method because of a low sensitivity for tetracyclines. Therefore,
scenarios with use of the bioassay and risk-based sampling were
ruled out.
As stated above, the scenarios modeled were analysed for
residues of penicillin and tetracycline, respectively.
The number of pigs sampled in the basic scenario reﬂecting the
current monitoring was by default set to 20,000 ﬁnishing pigs per
year corresponding to a slaughter population of 20 million ﬁnish-
ing pigs, hence 0.1% of the slaughter population, i.e. the ofﬁcial
monitoring and the abattoirs’ current own-check combined. For
the risk-based scenarios (scenario 3–6), the effect of two differ-
ent and reduced sampling schemes was  quantiﬁed—i.e. scenario 3
and 5) halving the intensity implying 10,000 samples divided into
5000 pigs from the HR-group and 5000 pigs from the LR-group, or
scenario 4 and 6) testing 7500 pigs from the HR-group and 5000
pigs from the LR-group (Table 2). These choices were based on
the abattoirs’ wish to avoid an increase in costs of monitoring as
well as a discussion with the marketing people in Danish Agricul-
ture & Food Council regarding export market requirements. This
also meant that a scenario involving random sampling using HPLC
LC–MS/MS on muscle samples was not considered feasible, because
it would result in a substantial increase in the costs.
2.5. Sensitivity and speciﬁcity of analytic methods
The last step in the scenario trees was  the detection node, in
which the sensitivity (Se) and the speciﬁcity (Sp) of the two different
analytical methods were modelled as pert distributions. The min-
imum,  most likely and maximum values for the HPLC LC–MS/MS
and the bioassay were estimated by expert opinion through contact
to the Danish Veterinary authorities’ laboratory for residue testing.
The two  laboratory experts (one was an expert in HPLC LC–MS/MS
method, the other was an expert in the bioassay method) were
interviewed by phone, and they were asked:
Sensitivity:• What is the most likely, highest, and lowest percentage of sam-
ples with residues of penicillin or tetracycline, respectively,
above MRL  level in kidney or muscle, respectively, which will
be detected?
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Speciﬁcity:
What is the most likely, highest, and lowest percentage of sam-
ples with no residues of penicillin and tetracycline, respectively,
in kidney or muscle, respectively, which could test false-positive?
.6. Model outputs
For each scenario, the conditional probabilities were calculated
or each branch in the tree by multiplying all proportions and prob-
bilities. The overall probability of being test-positive P(T+) was
alculated as the sum of all branch probabilities with a T+ out-
ome. The overall probability of being test-negative P(T−) was the
um of all probabilities from branches with T− outcomes. The total
xpected number of ﬁnishing pigs being T+ and T− were calculated
y multiplying P(T+) and P(T−), respectively, with the total number
f ﬁnishing pigs slaughtered per year (Spop).
The probability of false-positive test results was  calculated for
ach branch representing animals without residues above MRL
R−) by multiplying the relevant proportion and conditional prob-
bilities (Prop, 1-EPP,  sampling probability and 1-Sp)  in the given
ranch (Fig. 1). This was converted to the number of false-positive
est results in the given branch by multiplying with the number
f ﬁnishing pigs slaughtered per year (SPop). Finally, the numbers
rom each R- branch were summed up to obtain the total number
f false-positive test results (nFP) in the given monitoring sce-
ario. The same procedure was used to obtain the total number
f detected true residue cases (nDRC) in the branches representing
nimals with residues above MRL  (i.e. using the relevant Prop and
he conditional probabilities EPP, sampling probability and Se).
The expected number of cases of ﬁnishing pigs with residues
bove MRL  (Cpresent) was calculated as the sum of the expected
umber of ﬁnishing pigs with presence of residues in each risk
roup using the following equation (Eq. (3)):
present = ((SPop × PropLR) × EPPLR) + ((SPop × PropHR) × EPPHR)
(3)
here:
SPop is the total number of pig population slaughtered per year,
et to 20 million in all scenarios
PropLR is the proportion of slaughtered pigs that belongs to the
ow-risk group, set to 75% in the risk-based scenarios
PropHR is the proportion of slaughtered pigs that belongs to the
igh-risk group, set to 25% in the risk-based scenarios, and
EPPLR and EPPHR are the probabilities of residue presence for the
R and HR-group, respectively, calculated by use of Eqs. (1) and (2).
Initially, a Poisson distribution was used to describe the simu-
ated number of cases detected with residues. However, as most
utputs were 0, 1 or 2, this was not very helpful to identify differ-
nces in outputs of the various scenarios. Therefore, it was  decided
o abandon the use of a Poisson distribution, and use normal dis-
ributions allowing for decimal numbers in the output. To get the
umber of undetected cases (nURC) for each scenario the total num-
er of detected cases, nDRC, was subtracted from Cpresent. The
urveillance system sensitivity (SSSe) for each scenario was  calcu-
ated by dividing the nDRC by the Cpresent. The SSSe represents the
roportion of cases detected by the surveillance program.
.7. SimulationsThe models were set up in @Risk 6 (Palisade Corporation®, Mid-
lesex, UK) and run with 10,000 iterations and random seed. To
ccount for uncertainty, the input parameters were described by
se of distributions. Sensitivity analysis was performed by regres-y Medicine 128 (2016) 87–94 91
sion analysis for each scenario, identifying signiﬁcant outputs,
displayed as “tornado” type charts.
2.8. Input for cost comparison
The costs of one screening analysis when performed in large
scale by the largest slaughterhouse company in Denmark were
obtained from the head of laboratory of the slaughterhouse com-
pany (Andersen, personal communication, 2015). Accordingly, the
cost associated with use of the HPLC LC–MS/MS method was esti-
mated to D 10 per sample, and D 6 for a sample subjected to the
bioassay. These ﬁgures are without depreciation of the labora-
tory equipment. The price of the HPLC LC–MS/MS equipment was
D 33,000, VAT exclusive (Kirkeby, personal communication, 2015).
Moreover, there will be costs related to setting up the information
system to identify which pigs to sample.
3. Results
According to the two  experts contacted, the difference between
the two diagnostic methods regarding test characteristics was lim-
ited when kidney was used as matrix (Table 3). Therefore, the same
number of samples positive above MRL  was  expected, if the bioas-
say was  replaced by the HPLC LC–MS/MS both for penicillin and
tetracycline, when using kidney as the sampling matrix. According
to the experts, the speciﬁcity of the two  diagnostic methods was
close to one implying no false-negative test results.
The model predicted that the average number of samples
detected above MRL  in the current program would be 1.77 for peni-
cillin and 0.55 for tetracycline per year. The variation in mean total
number of detected cases was  very low; ranging from 1.48 in sce-
nario 3, to 2.32 in scenario 1 and 2. Hence, very low numbers of
positive samples would be expected. This is in accordance with the
ﬁgures displayed in Table 2, where it is noted that in some years no
positives were found, whereas in other years up to two  positives
were detected. Moreover, the vast majority of positive carcasses
were not found in the monitoring program; In all scenarios, around
2467 carcasses with residues above MRL  were estimated to pass
through the production chain unnoticed despite of the large num-
ber of samples taken as a part of the program. This is in line with
the low SSSe, which varied from 0.06% to 0.09% (Table 4).
The costs of using HPLC LC–MS/MS on an individual sample were
67% higher than the costs of using the bioassay (Table 4). The use of
risk-based sampling led to a more cost-effective monitoring com-
pared to using HPLC LC–MS/MS for the random sampling of residues
(scenario 3–6 versus scenario 2). Assuming a RR of 3 between the HR
and the LR-groups related to chronic pleuritis as well as sampling
7500 animals in the HR group and 5000 animals in the LR group
led to approximately the same mean number of positive samples
as random monitoring of 20,000 animals on average (2.26 versus
2.32-Scenario 6 versus scenario 1 and 2 in Table 4). If a RR of 2
was assumed, then a slightly lower average value was obtained
(1.97-Scenario 4 in Table 4). Hence, the variation in mean number
of detected cases was  very low, but the difference in costs was  large;
ranging from D 100,000 in scenarios 3 and 5 to D 200,000 in scenario
2. Scenario 6 had the lowest costs per case detected among the
risk-based scenarios investigated. Scenario 3 and 5 in fact resulted
in 17% lower costs than the current programme, but the costs per
case detected were higher than for the current program (Table 4).
The sensitivity analyses revealed that the input variables with
the highest impact on the output were the variables describing
the effective probability of presence of residues (EPP) in the ani-
mals originating from pigs in the HR or LR groups, respectively. The
EPP is very precisely estimated because several years of monitoring
data involving thousands of samples were included in the estimate
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Table 3
Input parameters for sensitivity (Se) and speciﬁcity (Sp) of two  different diagnostic methods for detection of antimicrobial residues in kidney and muscle tissue samples,
provided by laboratory experts from the Danish Veterinary and Food Administration, 2014.
Method Antibiotic Matrix Parameter Min  Mode Max
Bioassaya Penicillin Kidney Se 0.95 0.95 1
Sp 1 1 1
Muscle Se 0.96 0.96 1
Sp 1 1 1
Tetracycline Kidney Se 0.8 0.875 1
Sp 1 1 1
Muscle Se 0 0 0
Sp 1 1 1
HPLC
LC–MS/MS
Penicillin Kidney Se 1 1 1
Sp 1 1 1
Muscle Se 1 1 1
Sp 1 1 1
Tetracycline Kidney Se 1 1 1
Sp 1 1 1
Muscle Se 1 1 1
Sp 1 1 1
a The bioassay consisted of a microbiological four-plate test (NMKL 121, 2004) followed by a chemical veriﬁcation of positive samples.
Table 4
Simulated number of cases detected and undetected, number of animals tested, costs of surveillance and SSSea for residues of penicillin and tetracycline in Danish ﬁnishing
pigs,  for six scenarios involving different sample matrices and sample size combinations.
Scenario Antimicrobial Mean No. of cases >MRL (90% CI) No. of animals tested in Cost of sampling SSSea
Sampling Detected Undetected HRb group LRb group Total Total (D ) D per case %
1 Current randomc Penicillin 1.77 (0.57–3.30) 1850 (591–3439) 5000 15,000 20,000 120,000 51,724 0.09
Tetracycline 0.55 (0.17–1.01) 617 (197–1147)
Total 2.32 2467
2  Alternative randomd Penicillin 1.77 (0.57–3.30) 1850 (591–3439) 5000 15,000 20,000 200,000 86,207 0.09
Tetracycline 0.55 (0.18–1.01) 617 (197–1146)
Total 2.32 2467
3  Risk-basede
RR = 2
Penicillin 1.11(0.36–2.07) 1850 (591–3440) 5000 5000 10,000 100,000 67,568 0.06
Tetracycline 0.37 (0.12–0.69) 617 (197–1147)
Total 1.48 2467
4  Risk-basede
RR = 2
Penicillin 1.48 (0.47–2.75) 1850 (591–3440) 7500 5000 12,500 125,000 63,452 0.08
Tetracycline 0.49 (0.16–0.92) 617 (197–1147)
Total 1.97 2467
5  Risk-basede
RR = 3
Penicillin 1.23 (0.40–2.30) 1850 (591–3440) 5000 5000 10,000 100,000 60,976 0.07
Tetracycline 0.41 (0.13–0.77) 617 (197–1147)
Total 1.64 2467
6  Risk-basede
RR = 3
Penicillin 1.70 (0.54–3.16) 1850 (591–3439) 7500 5000 12,500 125,000 55,310 0.09
Tetracycline 0.56 (0.18–1.05) 617 (197–1146)
Total 2.26 2467
a Surveillance system sensitivity.
b HR = high risk; LR = Low risk.
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d In the alternative scenarios 2–5 the bioassay was  replaced by direct veriﬁcation
e Finishers from herds with >40% chronic pleuritis were assumed to have higher 
s well as information of test characteristics provided by labora-
ory experts. However, the relative risk (RR) for HR versus LR was
ssociated with a higher uncertainty. Therefore scenario analysis
as undertaken by assuming RR = 2 or RR = 3-see scenario 3–6 in
able 4.
. Discussion
.1. General performance
The results show that the prevalence of residues of antimicro-
ials in Danish ﬁnishing pigs is negligible, but they also show that
ost cases remain undetected despite that thousands of samplesre taken and analysed. This is reﬂected in the low SSSe in the
urrent random sampling and the alternative risk-based scenarios.
till, the surveillance is relevant, because it is important to show to
he farmers that withdrawal periods should be complied with.) applied to kidney samples followed by chemical veriﬁcation of positive samples.
 HPLC LC–MS/MS on muscle samples.
 residues according to Alban et al. (2014).
The value of the surveillance also lies in demonstrating to
consumers, trade partners, and national and international author-
ities that efforts are done to prevent residues of antimicrobials in
meat. Because consumers perceive residues as something that is
indeed unwanted in meat (TNS Opinion and Social, 2010), although
Berends et al. (2001), Baptista et al. (2010) and Alban et al. (2014)
have interpreted presence of residues of antimicrobials more as a
public health concern than a true food safety issue.
Testing of a low-prevalent condition requires a large number of
samples, and most samples are test-negative. In such a situation,
risk-based sampling becomes relevant (Stärk et al., 2006; Hadorn
and Stärk, 2008). The question is which factors are effective, efﬁ-
cient and practical. We  have so far only been able to identify one
suitable indicator for residues of antimicrobials in ﬁnishing pigs:
the within-herd prevalence of chronic pleuritis measured at the
time of slaughter (dichotomized into >40% and ≤40%), but further
investigations might identify other relevant risk factors or indica-
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ors. Other herd-level cluster-effects might be relevant for the risk
f residues being present in pigs going to slaughter, including the
armer’s system for ensuring that the withdrawal times are kept.
owever, this type of information is not available to the monitoring
ystem and hence cannot be used for risk-based sampling.
.2. Economic considerations
According to the information from one of the abattoirs, the HPLC
C–MS/MS diagnostic method is almost twice as expensive as the
ioassay. An interesting question was therefore, whether the use
f risk-based sampling could compensate for the increased costs?
his was apparently the case, when it was assumed that the animals
rom herds with >40% chronic pleuritis were associated with a two
r three times higher risk of having residues above MRL. Here, a
cenario involving either 5000 or 7500HR ﬁnishing pigs as well as
000 LR ﬁnishing pigs would only result in a slightly lower number
f positives compared to in the current program involving 20,000
amples (Table 4). It is questionable whether such small absolute
hanges in the number of test-positives will be noticeable at all in
he monitoring, and whether it will have any consequences for the
ims of the program.
Information about costs of the laboratory analyses was  pro-
ided by the abattoir company and was without depreciation of the
quipment and based on large-scale sampling. The prices may  eas-
ly be higher, if it is not the slaughterhouse’s own  laboratory which
s analysing the samples. This may  be the case for small abattoirs.
.3. Logistic challenges and advantage of the novel approach
Implementing a risk-based sampling approach would require
 change of the matrix from kidney to muscle because of logistic
roblems when trying to identify the animals that need to be tested
ompared to a program using random sampling. Here, an automatic
dentiﬁcation system based on previous records from the herds can
e applied, facilitating the sampling at the slaughterhouse. A similar
ystem is already in place for Salmonella in Danish ﬁnishing pigs,
here the pigs to be sampled in the cooling room are identiﬁed
utomatically over an entire slaughterday (Alban et al., 2012).
The HPLC LC–MS/MS method is more sensitive than the bioassay
t MRL  for residues of other antimicrobials used in the pig pro-
uction such as macrolides. Hence, more substances may  be found
n the years to come, although the ofﬁcial samples from 2012 to
013 did not reveal any positives despite of partial use of the HPLC
C–MS/MS (Table 2).
Concurrent analysis for a larger number of substances opens
p for use of monitoring as a way of documenting whether
llegal/prohibited drugs are used for livestock in the abattoirs’
wn-check. An example of this could be cephalosporins which are
rohibited by the Danish pig industry (Alban et al., 2013). How-
ver, some substances – such as tiamulins and aminoglycosides –
annot be analysed easily by the HPLC LC–MS/MS method, because
hey would require a separate puriﬁcation procedure and chemical
nalysis.
Use of HPLC LC–MS/MS implies that results (including substance
nd concentration) become available within a few days. This will
ake it easier to identify the reason for the presence during the
andatory follow-up visit to the herd, which is needed within a
ew days to ensure that the farmer can deliver pigs for slaughter the
ollowing week. Today, this is more difﬁcult, because time for full
iagnosis is longer (several days to weeks) after a positive reaction
n the bioassay.We  suggest to include both HR and LR pigs in the monitoring. If
nly HR pigs were included in the monitoring for residues, then only
ne fourth of the Danish pig population would be covered in the
onitoring. This might result in some farmers losing the incentivey Medicine 128 (2016) 87–94 93
to comply with the withdrawal period. Moreover, there are other
reasons for ﬁnding residues than a high within-herd prevalence of
chronic pleuritis as described by Alban et al. (2014); therefore, the
monitoring program needs to include samples taken at random or
in the LR group. It is expected that reducing the sample frequency in
the LR group will generally not reduce the preventive effect from
the monitoring program. An increased sampling in the HR group
may  – if communicated effectively – have a positive effect. In all
cases, information campaigns should be launched to all farmers
from time to another. Here, focus should be on use of correct mark-
ing of treated animals to prevent that these are delivered too early
to slaughter.
The HPLC LC–MS/MS method is capable of ﬁnding residues at
levels lower than MRL  implying that it will be possible to monitor
the level of residues of speciﬁc substances in the pigs slaughtered
even if they are not above MRL. The usefulness of this has been
pointed to by Olsen (2015), who focused on residues of tetracyclines
in pork exported to countries with lower MRL  than in the EU—such
as Russia.
The current monitoring within the EU shows that 0.13% of the
samples from pig meat were non-compliant, over-all speaking.
However, the monitoring programs vary between Member States,
which makes it difﬁcult to compare results (EFSA, 2014). The EU
Directive about residue monitoring will be up for negotiations
within a couple of years. It is expected that the future residue
monitoring of antimicrobial residues shall be based on guidelines
produced by EFSA, and hopefully the present study can act as a
valuable input to these guidelines enabling a cost-effective, harmo-
nized monitoring in all EU Member States—also for the inspiration
of countries outside the EU.
5. Conclusion
The more costly HPLC LC–MS/MS can replace bioassay as a
diagnostic method in the own-check for antimicrobial residues
in ﬁnishing pigs without an increase in total costs, if risk-based
sampling is applied. Sampling matrix will have to be muscle and
not kidney because of logistic challenges. This will result in a fast
response and a high sensitivity for a concurrent analysis of almost
all relevant substances used in pig production, hereby, providing
more effective responses to detection of residues of antimicrobials
in ﬁnishing pigs.
6. Epilogue
Based on the results shown in the present study, the Danish
pig industry decided to change to HPLC LC–MS/MS in their own-
check program by January 2016. The program involves risk-based
sampling using the within-herd prevalence of chronic pleuritis
prevalence as an indicator of high-risk herds (within-herd preva-
lence >40%) including 0.025% randomly selected ﬁnishing pigs
within the HR-group and 0.025% randomly selected ﬁnishing pigs
in the LR-group.
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